陈韵岱,骆景光

• 1: 首都医科大学附属北京安贞医院心内科
• 2:首都医科大学附属北京安贞医院心内科

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 陈韵岱,骆景光

参考文献(References)：

• [1]Carr ME.In vitro assessment of platelet function.Transfus MedRev,1997,11:106.
• [2]Nancy S Nicholson,Susan G Panzer2Knodle,Neal F Haes.As-sessment of platelet function assays.Am Heart J,1998,135:170.
• [3]Fox SC,Sasae R,Janson S,May JA,Heptinstall S:Quantita-tion of platelet aggregation and microaggregate formation in whole blood by flow cytometry.Platelets,2004,15:85-93.
• [4]Clinical and Research Laboratories.Platelet function analyzer(PFA)-100-FAQ.Available at.Accessed,2004.
• [5]Lanza GA,Sestito A,Iacovella S,et al.Relation between plate-let response to exercise and coronary angiographic findings in pa-tients with effort angina.Circulation,2003,107:1378-1382.
• [6]Frossard M,Fuchs I,Leitner JM,et al.Platelet function pre-dicts myocardial damage in patients with acute myocardial infarc-tion.Circulation,2004,110:1392-1397.
• [7]Storey RF,Heptiustall S.Laboratory investigation of platelet function.Clin Lab Haem,1999,21:317.
• [8]Coulter SA,Cannon CP,Ault KA,et al.High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarc-tion:results from TIMI(Thrombolysis in Myocardial Infarction)14.Circulation,2000,101:2690-2695.
• [9]Berger G,Hartwell DW,Wagner DD.P-selectin and platelet clearance.Blood,1998,92:4446-4452.
• [10]Michelson AD,Barnard MR,Krueger LA,et al.Flow cytome-try.In:Michelson AD,ed.Platelets.San Diego,Calif:Aca-demic Press,2002:297-315.
• [11]Furman MI,Benoit SE,Barnard MR,et al.Increased platelet reactivity and circulating monocyte platelet aggregates in patients with stable coronary artery disease.J AmColl Cardiol,1998,31:352-358.
• [12]Michelson AD,Barnard MR,Krueger LA,et al.Circulating monocyte platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin:studies in ba-boons,human coronary intervention,and human acute myocardi-al infarction.Circulation,2001,104:1533-1537.
• [13]Schonbeck U,Varo N,Libby P,et al.Soluble CD40L and car-diovascular risk in women.Circulation,2001,104:2266-2268.
• [14]Heeschen C,Dimmeler S,Hamm CW,et al.Soluble CD40lig-and in acute coronary syndromes.N Engl J Med,2003,348:1104-1111.
• [15]Eikelboom JW,Hirsh J,Weitz JI,et al.Aspirin-resistant throm-boxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events.Circulation,2002,105:1650-1655.